Cytokine Storm, cause of death in critical patients with COVID-19
Keywords:
Cytokine, Coronavirus, COVID-19, SARS-CoV-2, Immune SystemAbstract
Introduction: the SARS-CoV-2 coronavirus infection that causes COVID-19 can trigger an exaggerated reaction of the immune system, called Cytokine Storm, which could cause the serious development of the infection and even the death of patients. Objective: to describe the phenomenon of the Cytokine Storm in the immune response of the human body to infection by the SARS-CoV-2 coronavirus as a cause of death in critically ill patients with COVID-19. Material and methods: a bibliographic review was carried out, where the various theoretical synthesis methods were used and a total of 35 articles were selected in sources such as Scielo, Infomed, national and international medical science journals. Development: when the SARS-CoV-2 coronavirus enters the body, the immune system identifies it and attacks it through antibodies, which try to eliminate the external factor and then go back. However, in some conditions, there is an overactive immune reaction that causes uncontrolled production of antibodies, which not only attack foreign pathogens, but can become confused and attack healthy cells and tissues of the body, this is known as a storm cytokine, which could explain the severity in which critically ill patients developed COVID-19 disease. Conclusions: in critically ill patients with COVID-19, an autoimmune reaction is triggered that causes inflammation in various tissues of the body. The most serious damage occurs in the lung, and these pathophysiologies are expected to be caused by a resulting cytokine storm that disrupts the normal immune response.
References
Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID 19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Alergy Immunol (Internet(. 2020 (citado 15/07/2020(; 38(1):1-9. Disponible en: http://apjai-journal.org/wp-content/uploads/2020/03/1.pdf?fbclid=IwAR1kVlFnoc6mobqEy7FDz_93fX__AaY8ZgE4TUwtjzhh8oVqgs82rgf3QoU
Geng Li, Yaohua Fan, Yanni Lai, Tiantian Han, Zonghui Li, Peiwen Zhou, et al. Coronavirus infections and immune responses. J Med Virol [Internet]. 2020 [citado 15/07/2020]; 92(4):24-32. Disponible en: https://doi.org/10.1002/jmv.25685
Diccionario de cáncer del NCI. 21 ed. Estados Unidos: Instituto Nacional del Cáncer Grupo Editorial; 2020. Tormenta de citocinas.
Martínez Díaz E, Pérez Rodríguez R, Herrera Martínez L, Lage Dávila A, Serra Castellanos L. La industria biofarmacéutica cubana en el combate contra la pandemia de COVID-19. Anales de la Academia de Ciencias de Cuba [Internet]. 2020 [citado 15/07/2020]; 10(2):e906. Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/906/849
Pertejo Alcamí J. La respuesta inmune frente a SARS-CoV-2, ¿un arma de doble filo? RIECS [Internet]. 2020 [citado 15/07/2020]; 5(1):134-142. Disponible en: https://doi.org/10.37536/RIECS.2020.5.1.212
Lozana RequenaI, Nuez Ponce C. COVID-19: Respuesta inmune y perspectivas terapéuticas. Rev Perú Med Exp Salud Pública [Internet]. 2020 [citado 15/07/2020]; 37(2):312-319. Disponible en: http://dx.doi.org/10.17843/rpmesp.2020.372.5490
WHO. Transmisión del SARS-CoV-2: repercusiones sobre las precauciones en materia de prevención de infecciones [Internet]. 2020 [citado 15/07/2020]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/333390/WHO-2019-nCoV-Sci_modes-2020.3-spa.pdf
Pérez GA., Cordero CR., Avendaño CLF. Otro desafío de la naturaleza: el nuevo coronavirus virología y fisiopatología del SARS-CoV-2. Neumol Pediatr [Internet]. 2020 [citado 15/07/2020]; 15(2):301-307. Disponible en: https://www.neumologia-pediatrica.cl/index.php/NP/article/view/69
Suárez Reyesa A, Villegas Valverde CA. Características y especialización de la respuesta inmunitaria en la COVID-19. Rev. Fac. Med [Internet]. 2020 [citado 15/07/2020]; 63(4):00243849. Disponible en: http://doi.org/10.22201/fm.24484865e.2020.63.4.02
López Pérez GT, Ramírez Sandoval MLP, Torres Altamirano MS. Participantes de la respuesta inmunológica ante la infección por SARS-CoV-2. Artículo de Revisión. Alergia e Inmunol. Pediátr [Internet]. 2020 [citado 15/07/2020]; 29(1):5-15. Disponible en: https://dx.doi.org/10.35366/93321
León Delgado J, Pareja Cruz A, Aguilar Ramírez P, Enríquez Valencia Y, Quiroz Carrillo C, Valencia Ayala E. SARS-CoV y el sistema inmune: una batalla entre titanes. Artículo de Revisión. Rev Med [Internet]. 2020 [citado 15/07/2020]; 20(2):e1209. Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1727-558X2020000200012&script=sci_arttext
López Pérez GT, Ramírez Sandoval MLP, Torres Altamirano MS. Fisiopatología del daño multiorgánico en la infección por SARS-CoV-2. Acta Pediatr Mex [Internet]. 2020 [citado 15/07/2020]; 41(1):27-41. Disponible en: https://ojs.actapediatrica.org.mx/index.php/APM/article/view/2042
Porras O. Linfohistiocitosis hemofagocítica, el espectro desde la enfermedad genética al síndrome de activación macrofágica. Acta méd. costarric [Internet]. 2011 [citado 15/07/2020]; 53(2):71-78. Disponible en: https://www.scielo.sa.cr/scielo.php?pid=s0001-60022011000200004&script=sci_abstract&tlng=es
Ganji A, Farahani I, Khansarinejad B, Hhazavi A, Mosayebi G. Increased expression of CD8 marker on T-cells in COVID-19 patients. BloodCells Mol Dis [Internet]. 2020 [citado 15/07/2020]; 83(3):102437. Disponible en: https://www.sciencedirect.com/science/article/pii/S1079979620301364
García-Salido A. Revisión narrativa sobre la respuesta inmunitaria frente a coronavirus: descripción general, aplicabilidad para Sars-Cov2 e implicaciones terapéuticas. An. Pediatr. [Internet]. 2020 [citado 15/07/2020]; 93(1):601-607. Disponible en: https://www.analesdepediatria.org/es-revision-narrativa-sobre-respuesta-inmunitaria-articulo-S1695403320301727
Dandan W, Xuexian OY. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. J Microb, Immunol Infect [Internet]. 2020 [citado 15/07/2020]; 53(3):368-370. Disponible en: https://doi.org/10.1016/j.jmii.2020.03.005
Maloir Q, Ghysen K, von Frenckell C, Louis R, Guiot J. Acute respiratory distress revealing antisynthetase syndrome. Rev Med Liege [Internet]. 2018 [citado 15/07/2020]; 73(7-8):370-375. Disponible en: https://www.rmlg.ulg.ac.be/show.php
Ng OW, Chia A, Tan AT, Jadi RS, Leong HN, Bertoletti, et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years’ post-infection. Vaccine [Internet]. 2016 [citado 15/07/2020]; 34(17):2008-2014. Disponible en: http://dx.doi.org/10.1016/j.vaccine.2016.02.063
Li X, Geng M, Peng Y, Meng L, Lu Sh. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharmaceutical Analysis [Internet]. 2020 [citado 15/07/2020]; 10(2):102-108. Disponible en: https://www.sciencedirect.com/science/article/pii/S2095177920302045
Channappanava R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol [Internet]. 2017 [citado 15/07/2020]; 39(5):529-539. Disponible en: https://doi.org/10.1007/s00281-017-0629-x
Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents [Internet]. 2020 [citado 15/07/2020]; 34(2):327-331. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32171193/
Amezcua-Guerra LM. Anotaciones breves sobre el síndrome de liberación de citocinas y el bloqueo terapéutico de la interleucina-6 en SARS-CoV-2/COVID-19. Cardiovasc Metab Sci [Internet]. 2020 [citado 15/07/2020]; 31(3):255-258. Disponible en: https://dx.doi.org/10.35366/93956
Francisco ALM, Pérez Canga JL. Coronavirus y Riñón. ACTUALIZACIÓN COMPLETA 09 de junio de 2020. Servicio de Nefrología Hospital Universitario Valdecilla, Santander [Internet]. 2020 [citado 15/07/2020]. Disponible en: https://www.nefrologiaaldia.org/es-articulo-coronavirus-rinon-actualizacion-completa-09-305
Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev [Internet]. 2012 [citado 15/07/2020]; 76(1):16-32. Disponible en: https://doi.org/10.1128/MMBR.05015-11
Ling Lin, Lianfeng Lu, Wei Cao, Taisheng Li. Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia. Emerging Microbes & Infections [Internet]. 2020 [citado 15/07/2020]; 9(1):727-732. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC717033
Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology [Internet]. 2020 [citado 15/07/2020]; 77(2):198-209. Disponible en: https://doi.org/10.1111/his.14134
Liao M, Liu Yang, Yuan Jin, Wen Yanling, Xu Gang, Zhao Juanjuan, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. medRxiv [Internet].2020 [citado 15/07/2020]; 26:842-844. Disponible en:https://doi.org/10.1101/2020.02.23.20026690
Yueying Li, Shu-Yuan Xiao. Hepatic Involvement in COVID-19 Patients: Pathology, Pathogenesis, and Clinical Implications. J Med Virol [Internet]. 2020 [citado 15/07/2020]; 92(9):1491-1494. Disponible en: https://doi.org/10.1002/jmv.25973
Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol [Internet]. 2020 [citado 15/07/2020]; 16(6):308-310. Disponible en: https://doi.org/10.1038/s41581-020-0284-7
Parra Izquierdo V, Flórez Sarmiento C, Romero Sánchez C. Inducción de “Tormenta de citocinas” en pacientes infectados con SARS- CoV-2 y desarrollo de COVID-19. ¿Tiene el tracto gastrointestinal alguna relación en la gravedad? Rev Colomb Gastroenterol [Internet]. 2020 [citado 15/07/2020]; 35(1):21-29. Disponible en: https://doi.org/10.22516/25007440.539
Salvo Romero E, Cotoner M del CA, Camacho CP, Casado Bedmar M, Vicario M. Función barrera intestinal y su implicación en enfermedades digestivas. Rev Esp Enferm Cavar [Internet]. 2015 [citado 15/07/2020]; 107(11):686-696. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-0108201500110007
Mönkemüller K, Fry L, Rickes S. COVID-19, Coronavirus, SARSCoV-2 and the Small Bowel. Rev Esp Enferm Dig [Internet]. 2020 [citado 15/07/2020]; 112(5):383-388. Disponible en: https://doi.org/10.17235/reed.2020.7137/2020
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal, accept the following terms:
The authors will retain their copyright and guarantee the journal the right of first publication of your work, which will be under a Creative license Commons Attribution-NonCommercial-ShareAlike 4.0 International . (CC BY-NC-SA 4.0).
The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (eg:deposit it in an institutional telemat